Labcorp Inc. (LH)
NYSE: LH
· Real-Time Price · USD
278.47
3.24 (1.18%)
At close: Sep 05, 2025, 3:59 PM
278.67
0.07%
After-hours: Sep 05, 2025, 07:28 PM EDT
Labcorp Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LabCorp Diagnostics Revenue | 2.75B | 2.63B | 2.59B | 2.55B | 2.52B | 2.48B | 2.35B | 2.34B | 2.34B | 2.38B | 9.2B | 2.21B | 2.26B | 2.45B | 10.36B | 2.62B | 2.37B | 2.76B | 9.25B | 2.7B | 1.69B | 1.7B | 6.66B | 1.76B | 1.76B | 1.72B | 6.66B | 1.75B | 1.81B | 1.77B | 14.34B | 1.84B | 1.8B | 1.72B | 13.19B | 1.67B | 1.66B | 1.59B | 12.4B | 6.25B | 4.62B | 1.47B | 5.68B | 1.47B | 1.43B | 1.35B | 5.47B | 1.38B | 1.38B |
| LabCorp Diagnostics Revenue Growth | +4.53% | +1.68% | +1.28% | +1.13% | +1.82% | +5.66% | +0.09% | +0.17% | -1.76% | -74.11% | +316.90% | -2.12% | -8.10% | -76.32% | +295.94% | +10.65% | -14.23% | -70.20% | +242.19% | +59.76% | -0.55% | -74.45% | +278.73% | -0.10% | +2.26% | -74.16% | +280.38% | -3.42% | +2.47% | -87.66% | +680.59% | +2.12% | +4.73% | -86.97% | +688.84% | +0.73% | +4.34% | -87.17% | +98.42% | +35.20% | +213.99% | -74.09% | +286.83% | +2.63% | +6.00% | -75.29% | +296.66% | -0.28% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2015 |
|---|---|---|---|---|---|
| United States Revenue | 2.93B | 3.35B | 3.09B | 3.47B | 7B |
| United States Revenue Growth | -12.56% | +8.46% | -10.98% | -50.42% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 579.3M | 546M | 595.2M | 568.6M | 557.8M | 508.4M | 532.9M | 525.5M | 505.8M | 553.6M | 536.5M | 510M | 486M | 464.1M | 543.7M | 519.9M | 458.7M | 429.8M | 518M | 419.5M | 396.3M | 395.5M | 413.9M | 401.5M | 415.3M | 393.8M | 396.9M | 381.8M | 395.2M | 397M | 492.4M | 465.3M | 435.3M | 419.4M | 406M | 400.5M | 408M | 411.9M | 404.9M | 382.5M | 392.4M | 415.1M |
| Selling, General, and Administrative Revenue Growth | +6.10% | -8.27% | +4.68% | +1.94% | +9.72% | -4.60% | +1.41% | +3.89% | -8.63% | +3.19% | +5.20% | +4.94% | +4.72% | -14.64% | +4.58% | +13.34% | +6.72% | -17.03% | +23.48% | +5.85% | +0.20% | -4.45% | +3.09% | -3.32% | +5.46% | -0.78% | +3.95% | -3.39% | -0.45% | -19.37% | +5.82% | +6.89% | +3.79% | +3.30% | +1.37% | -1.84% | -0.95% | +1.73% | +5.86% | -2.52% | -5.47% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |